ATE277176T1 - Faltende proteine - Google Patents
Faltende proteineInfo
- Publication number
- ATE277176T1 ATE277176T1 AT95907076T AT95907076T ATE277176T1 AT E277176 T1 ATE277176 T1 AT E277176T1 AT 95907076 T AT95907076 T AT 95907076T AT 95907076 T AT95907076 T AT 95907076T AT E277176 T1 ATE277176 T1 AT E277176T1
- Authority
- AT
- Austria
- Prior art keywords
- subunits
- complex
- polypeptides
- folding
- expression
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 101100260051 Caenorhabditis elegans cct-1 gene Proteins 0.000 abstract 1
- 101100152619 Drosophila melanogaster CCT1 gene Proteins 0.000 abstract 1
- 102000004243 Tubulin Human genes 0.000 abstract 1
- 108090000704 Tubulin Proteins 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Gyroscopes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9401791A GB9401791D0 (en) | 1994-01-31 | 1994-01-31 | Folding proteins |
| GB9418234A GB9418234D0 (en) | 1994-01-31 | 1994-09-09 | Folding proteins |
| PCT/GB1995/000192 WO1995020654A1 (en) | 1994-01-31 | 1995-01-31 | Folding proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE277176T1 true ATE277176T1 (de) | 2004-10-15 |
Family
ID=26304239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95907076T ATE277176T1 (de) | 1994-01-31 | 1995-01-31 | Faltende proteine |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6255070B1 (de) |
| EP (1) | EP0742822B1 (de) |
| JP (1) | JPH10500001A (de) |
| AT (1) | ATE277176T1 (de) |
| AU (1) | AU1541395A (de) |
| CA (1) | CA2182499A1 (de) |
| DE (1) | DE69533545T2 (de) |
| WO (1) | WO1995020654A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9710762D0 (en) * | 1997-05-23 | 1997-07-23 | Cancer Res Inst Royal | Binding complexes |
| FR2782085B1 (fr) * | 1998-08-05 | 2002-12-13 | Fond Jean Dausset Ceph | Genes impliques dans les voies moleculaires de la suppression tumorale et/ou la resistance aux virus |
| WO2002041827A2 (en) | 2000-11-24 | 2002-05-30 | Vascular Biogenics Ltd. | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| JP4675647B2 (ja) * | 2005-03-03 | 2011-04-27 | 株式会社ダイヤメット | ステータ、回転機用コア及び回転機 |
| EP1874334A4 (de) * | 2005-04-15 | 2011-03-30 | Vascular Biogenics Ltd | Zusammensetzungen mit von beta 2-glykoprotein i stammenden peptiden zur prävention und/oder behandlung von gefässerkrankungen |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993025681A1 (en) * | 1992-06-11 | 1993-12-23 | New York University | A cytoplasmic chaperonin and methods of making and using it |
-
1995
- 1995-01-31 DE DE69533545T patent/DE69533545T2/de not_active Expired - Fee Related
- 1995-01-31 CA CA002182499A patent/CA2182499A1/en not_active Abandoned
- 1995-01-31 JP JP7519956A patent/JPH10500001A/ja not_active Ceased
- 1995-01-31 AU AU15413/95A patent/AU1541395A/en not_active Abandoned
- 1995-01-31 EP EP95907076A patent/EP0742822B1/de not_active Expired - Lifetime
- 1995-01-31 US US08/687,590 patent/US6255070B1/en not_active Expired - Lifetime
- 1995-01-31 WO PCT/GB1995/000192 patent/WO1995020654A1/en not_active Ceased
- 1995-01-31 AT AT95907076T patent/ATE277176T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2182499A1 (en) | 1995-08-03 |
| JPH10500001A (ja) | 1998-01-06 |
| AU1541395A (en) | 1995-08-15 |
| DE69533545D1 (de) | 2004-10-28 |
| WO1995020654A1 (en) | 1995-08-03 |
| EP0742822B1 (de) | 2004-09-22 |
| US6255070B1 (en) | 2001-07-03 |
| DE69533545T2 (de) | 2006-01-05 |
| EP0742822A1 (de) | 1996-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vandekerckhove et al. | Coexpression of a mutant β-actin and the two normal β-and γ-cytoplasmic actins in a stably transformed human cell line | |
| Hackeng et al. | Total chemical synthesis of human matrix Gla protein | |
| BG100771A (bg) | Хематопоетичен протеин и материали и методи за неговото получаване | |
| ATE257160T1 (de) | Peptidsequenzen als scharnierregionen in proteinen wie immunglobulinfragmenten und ihre verwendung in der heilkunde | |
| Dixon et al. | Isolation, amino acid sequence and copper (II)-binding properties of peptide (1–24) of dog serum albumin | |
| NO894503D0 (no) | Uretan-beskyttede aminosyre-n-karboksyanhydrider. | |
| ATE49233T1 (de) | Vektoren zur transformation von hefe. | |
| DE69129865D1 (de) | Osteogene peptide | |
| TR200003181T2 (tr) | Gelişmiş çoğaltılabilirliğe sahip FAP alfa'ya özgü antikor | |
| DE69939330D1 (de) | Wachstumsfaktor-homologe zvegf-3 | |
| DE69019190D1 (de) | Pankreatische Isletzellen-Antigene, erhalten durch molekulare Klonierung. | |
| DE3881023D1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
| DE69533545D1 (de) | Faltende proteine | |
| ATE317443T1 (de) | N-terminal verlängerte proteine exprimiert in hefe | |
| EP0815136A4 (de) | Immunoreaktive und immunotherapeutische moleküle welche in individuen mit insulin-abhängiger diabetes mellitus interagieren | |
| Pozzi et al. | Chemical synthesis and characterization of wild‐type and biotinylated N‐terminal domain 1–64 of β2‐glycoprotein I | |
| DE59712771D1 (de) | Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung | |
| WO1992011370A3 (de) | Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung | |
| BR0010479A (pt) | Gene tipo prp | |
| WO2001064913A3 (en) | Cell cycle proteins associated with rad9, compositions and methods of use | |
| DE3782549D1 (de) | Neue polypeptide, ihre herstellung und ihre verwendung. | |
| DE69832299D1 (de) | Einkettigen polypeptiden enthalten troponin i und troponin c | |
| WO1995021916A3 (en) | Pp32: a newly identified cd45-associated protein | |
| Bushuev et al. | A comparative study of structural properties of fibronectin and its 180 kDa fragment | |
| DE59106997D1 (de) | Ancrod ähnliche proteine, ihre herstellung und verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |